Brief: Ryvu Therapeutics Signs Deal With Medical Research Agency For Up to 62.3 Mln Zloty Subsidy
July 31 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* SIGNS DEAL WITH MEDICAL RESEARCH AGENCY
* DEAL ON ABOUT 62.3 MILLION ZLOTY SUBSIDY FOR RIVER-81
PROJECT
* AIM OF PROJECT IS TO DEVELOP A NEW TREATMENT STRATEGY FOR
ACUTE
MYELOID LEUKEMIA (AML) BY CONDUCTING RIVER-81 STUDY
Source text for Eikon: ID:nEMxwCJPa
Further company coverage: RVU.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; 48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project